251 related articles for article (PubMed ID: 26114737)
1. Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.
De Hert M; Peuskens J; Sabbe T; Mitchell AJ; Stubbs B; Neven P; Wildiers H; Detraux J
Acta Psychiatr Scand; 2016 Jan; 133(1):5-22. PubMed ID: 26114737
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic treatment, prolactin, and breast tumorigenesis.
De Hert M; Vancampfort D; Stubbs B; Sabbe T; Wildiers H; Detraux J
Psychiatr Danub; 2016 Sep; 28(3):243-254. PubMed ID: 27658833
[TBL] [Abstract][Full Text] [Related]
3. [Prolactin, antipsychotics and breast cancer: is there a connection?].
Sabbe T; Detraux J; De Hert M
Tijdschr Psychiatr; 2016; 58(9):641-9. PubMed ID: 27639886
[TBL] [Abstract][Full Text] [Related]
4. Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.
De Hert M; Detraux J; Stubbs B
Expert Opin Drug Saf; 2016 Jun; 15(6):809-23. PubMed ID: 26986209
[TBL] [Abstract][Full Text] [Related]
5. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.
Peuskens J; Pani L; Detraux J; De Hert M
CNS Drugs; 2014 May; 28(5):421-53. PubMed ID: 24677189
[TBL] [Abstract][Full Text] [Related]
6. Hyperprolactinemia Induced by Antipsychotics: From Diagnosis to Treatment Approach.
Milano W; Colletti C; Capasso A
Endocr Metab Immune Disord Drug Targets; 2017; 17(1):38-55. PubMed ID: 28440197
[TBL] [Abstract][Full Text] [Related]
7. Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A review.
Froes Brandao D; Strasser-Weippl K; Goss PE
Cancer; 2016 Jan; 122(2):184-8. PubMed ID: 26457577
[TBL] [Abstract][Full Text] [Related]
8. Effect of antipsychotic-induced hyperprolactinemia on anthropometric measures, insulin sensitivity and lipid profile in patients with schizophrenia or related psychoses.
Melkersson K; Berinder K; Hulting AL
Neuro Endocrinol Lett; 2011; 32(4):428-36. PubMed ID: 21876517
[TBL] [Abstract][Full Text] [Related]
9. Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia.
Poyraz BC; Aksoy C; Balcioğlu I
Eur Neuropsychopharmacol; 2008 Sep; 18(9):667-72. PubMed ID: 18539008
[TBL] [Abstract][Full Text] [Related]
10. Prolactin gene polymorphism (-1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics.
Ivanova SA; Osmanova DZ; Boiko AS; Pozhidaev IV; Freidin MB; Fedorenko OY; Semke AV; Bokhan NA; Kornetova EG; Rakhmazova LD; Wilffert B; Loonen AJ
Schizophr Res; 2017 Apr; 182():110-114. PubMed ID: 27776952
[TBL] [Abstract][Full Text] [Related]
11. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotics-induced hyperprolactinemia and screening for macroprolactin.
Ruljancic N; Bakliza A; Vuk Pisk S; Geres N; Matic K; Ivezic E; Grosic V; Filipcic I
Biochem Med (Zagreb); 2021 Feb; 31(1):010707. PubMed ID: 33380894
[TBL] [Abstract][Full Text] [Related]
13. Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects.
Halbreich U; Kinon BJ; Gilmore JA; Kahn LS
Psychoneuroendocrinology; 2003 Jan; 28 Suppl 1():53-67. PubMed ID: 12504072
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?
O'Keane V; Meaney AM
J Clin Psychopharmacol; 2005 Feb; 25(1):26-31. PubMed ID: 15643097
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives.
Byerly M; Suppes T; Tran QV; Baker RA
J Clin Psychopharmacol; 2007 Dec; 27(6):639-61. PubMed ID: 18004132
[TBL] [Abstract][Full Text] [Related]
16. Alcohol Use Disorders Identification Test (AUDIT) scores are elevated in antipsychotic-induced hyperprolactinaemia.
Lawford BR; Barnes M; Connor JP; Heslop K; Nyst P; Young RM
J Psychopharmacol; 2012 Feb; 26(2):324-9. PubMed ID: 21262859
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland.
Taipale H; Solmi M; Lähteenvuo M; Tanskanen A; Correll CU; Tiihonen J
Lancet Psychiatry; 2021 Oct; 8(10):883-891. PubMed ID: 34474013
[TBL] [Abstract][Full Text] [Related]
18. Schizophrenia, antipsychotics and risk of hip fracture: a population-based analysis.
Sørensen HJ; Jensen SO; Nielsen J
Eur Neuropsychopharmacol; 2013 Aug; 23(8):872-8. PubMed ID: 23642346
[TBL] [Abstract][Full Text] [Related]
19. Association between long-term use of prolactin-elevating antipsychotics in women and the risk of breast cancer: What are the clinical implications?
Hope JD; Keks NA; Copolov DL
Australas Psychiatry; 2023 Apr; 31(2):205-208. PubMed ID: 36927059
[TBL] [Abstract][Full Text] [Related]
20. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.
Byerly MJ; Marcus RN; Tran QV; Eudicone JM; Whitehead R; Baker RA
Schizophr Res; 2009 Feb; 107(2-3):218-22. PubMed ID: 19038534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]